- Former Merck CEO, Ken Frazier
- Former Head of FDA, Scott Gottlieb
- CRISPR Gene Therapy Patient Keynote, Victoria Gray
- Tuft's Ken Getz
- How DPHARM is tackling AI
- What to do about Protocol Complexity
- and more
In this podcast series, DPHARM Director Tracey Kimball with Valerie Bowling, Executive Director of the Conference Forum, break down what to expect at DPHARM 2025. Part I of this podcast series covers keynotes and key topics for this year's event, including:
For Part II, which covers the pharma case studies that will be presented at DPHARM, click here. For the full agenda, visit DPHARMconference.com.
Related Podcasts
View All
Are Site Networks the Solution to the Industry Productivity and Recruitment Challenge?
Biogen Pilot on Using Vocal Biomarkers to Identify Potential Trial Participants: From the DPHARM 2024 Archives
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives

